Archive of Members
We are proud to connect so many ILD minded WASOG members all over the world.
WASOG is committed to strengthening mutual contact and providing information about ILD.
Read more about all our members on this page. Together we can achieve more.
Alistair Miller
Respiratory Physician
Royal Melbourne Hospital, Respiratory and sleep medicine, 300 Grattan St, 3050, Australia
ILD Drug induced lung disease
Paul Thomas
Professor at University of New South Wales, High Street, Randwick NSW 2031
Sarcoidosis, Breath analysis, T-CELL Biology; Clinical and Research
Christopher Zappala
Doctor
Royal Brisbane and Woman's Hospital, Thoracic Specialist, Herston Rd, Herston QLD 4006, Australia
ILD, Pulmonary Hypertension
Helmut Prosch
Assoc. Prof.
Medical University of Vienna, Dept. of Biomedical Imaging and Image-guided Therapy, Währigergürtel 18-20, Vienna 1090, Austria
Radiology
Thomas Weichhart
Associate Professor, PhD, Principal Investigator
Medical University of Vienna, Center for Pathbiochemistry and Genetics, Währingerstrasse 10, 1090 Vienna
Innate Immunity, mTOR, granulomatous diseases, sarcoidosis
Nico De Crem
MD, Pulmonologist
University Hospitals Leuven, Respiratory Diseases, Herestraat 49, 3000 Leuven, Belgium
Thomas Planté-Bordeneuve
MD, PhD; Professor UC Louvain
CHU-UCL Namur, Respiratory Medicine, Avenue Gaston Therasse 1, 5530 Yvoir, Belgium
Hans Slabbynck
ZNA Middelheim, Lindendreef 1, Antwerp
ILD IPF orphans diseases
Dimitar Petrov
MD
Specialised Hospital for Active Treatment for Pneumophthisiatric Diseases Dr. Dimitar Gramatikov - Ruse, Pulmonology department, Ruse 1, Aleya Lilia str., 7002, Bulgaria
Meyer Balter
Professor of Medicine, University of Toronto Director, Asthma and COPD Education Clinic, Mount Sinai Hospital, 600 University Avenue, Suite 4-433, Toronto, Ontario M5G 1X5
Sarcoidosis, asthma, COPD
David Birnie
Birnie BSc (Hons), MB ChB, MRCP(UK), MD Vered Chair and Head, Division of Cardiology Faculty of Medicine Tier 1 Clinical Research Chair in Cardiac Electrophysiology Staff Cardiac Electrophysiologist, University of Ottawa Heart Institute
BSc(Hons), MB ChB, MRCP(UK), MD, University of Ottawa Heart Institute, 40 Ruskin Street Room H1285A, K1Y 4W7 Ottawa
Dr. David Birnie was appointed staff cardiac electrophysiologist (EP) at the University of Ottawa Heart Institute (UOHI) in May 2002. He was educated in Scotland and received his medical degree (MB ChB) from Glasgow University in 1990. He spent three years as a cardiology research fellow at Glasgow University from 1993 studying the immunology of atherosclerosis and was awarded his PhD equivalent (MD) in 1996. Between 1996 and 2001 he completed cardiology training in Glasgow and spent a year in 1999-2000 as an EP fellow at UOHI. His clinical focus is on all aspects of cardiac EP including radiofrequency ablation of simple and complex arrhythmias and implantation and follow-up of device therapy. He also has a major clinical interest in Cardiac Sarcoidosis and co-initiated (in 2008) and still co-leads Canada’s first dedicated Cardiac Sarcoidosis clinic. His major ongoing research interests are cardiac sarcoidosis, selection and optimization of CRT for heart failure patients, investigating optimal strategies for complication reduction around EP procedures. To date he has been involved in over 400 peer-reviewed publications; highlights include -Birnie et al Pacemaker or defibrillator surgery without interruption of anticoagulation. N. Engl. J Med. 2013 Birnie et al HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014 Birnie DH Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol. 2019 He has had continuous peer reviewed funding since 2004 and holds current grants from CIHR and Heart and Stroke Foundation of Canada. He is founding member of the Canadian Heart Rhythm Society and is past chair of the research committee. In 2020 he was elected to the executive committee of the World Association of Sarcoidosis (WASOG). He has managed to combine work with his major passion/hobby; serving as cardiologist for the medical advisory committee of the Canadian Soccer Association.
Chrystal Chan
Clinical Assistant Professor
University of Alberta, Department of Medicine, 11101 University Ave NW, T6G 1Y5, Canada
Onofre Moran
MD PhD MSc, respirologist, Director ILD Program
Kingston Health Sciences Center. Queen's University, Respiratory and Sleep Medicine, 102 Stuart Street Kingston, Ontario K7L 2V6
ILD, IPF
Jodie Roberts
Assistant Professor
University of Calgary, Clinical Neurosciences and Community Health Sciences, 1602 9 St NW, T2M 3L4, Canada
Neurosarcoidosis; Epidemiology; Health Outcomes
Elisabeth Bendstrup
Professor, Ph.D., MD, Senior Consultant
Aarhus University Hospital, Department of Respiratory Diseases and Allergy, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
Sarcoidosis, IPF, ILD, PAM, PAP
Keld-Erik Byg
MD
Odense University Hospital Rheumatology, J.B. Winsloewsvej 4, 5000 Odense
Sarcoidosis, neuroinflammation, autoinflammatory syndromes
Juliana Gjørup
Doctor
Hospital, Lungmedicine, Lindevej 29, 4140, Borup, Denmark
Lungdiseases , ILS
Dominique Israel-Biet
Professor Emeritus of Respiratory Medicine
University Paris Cité, Hôpital Européen Georges Pompidou, Paris 75015, France
Francesco Bonella
MD, Professor of interstitial and rare lung diseases
Center for interstitial and rare lung diseases, Pulmonology Department, Ruhrlandklinik University Hospital, University of Duisburg-Essen Tueschener Weg 40, 45239 Essen, Germany
ILD, Sarcoidosis, rare and ultra-rare lung diseases, biomarkers and genetics
Ulrich Costabel
Ruhrlandklinik, Tueschener Weg 40, 45239 Essen